PMGC (ELAB) vs Genprex (GNPX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
PMGC is the larger company by market cap ($2.5 million vs $2.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAB | GNPX |
|---|---|---|
| Share price | $3.07 | $2.93 |
| Market cap | $2.49M | $2.40M |
| 1-day change | -1.29% | +6.55% |
| EPS (TTM) | $-1,748.36 | $-9.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2,671.20 | $1,210.00 |
| 52-week low | $2.59 | $2.53 |
| Distance from 52-week high | -99.89% | -99.76% |
| Average volume | 127.38K | 247.06K |
| Shares outstanding | 809.58K | 819.71K |
| Employees | 32 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
ELAB vs GNPX FAQ
Which is bigger, PMGC or Genprex?
PMGC (ELAB) is larger, with a market capitalization of $2.49M compared with $2.40M for Genprex (GNPX).
Are PMGC and Genprex in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.